A Review of 11 Years ofStenotrophomonas maltophiliaBlood Isolates at a Tertiary Care Institute in Canada | Zendy

Prenilla Naidu | Zendy; Stephanie S. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Review of 11 Years ofStenotrophomonas maltophiliaBlood Isolates at a Tertiary Care Institute in Canada

Author(s) -

Prenilla Naidu,

Stephanie S. Smith

Publication year - 2012

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 38

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2012/762571

Subject(s) - stenotrophomonas maltophilia , medicine , bacteremia , intensive care unit , infection control , drug resistance , ticarcillin , emergency medicine , tertiary care , pediatrics , intensive care medicine , antibiotic resistance , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , imipenem , biology , bacteria , genetics

Stenotrophomonas maltophilia has emerged as a significant nosocomial pathogen with increasing resistance to trimethoprim/sulphamethoxazole (TMP/SMX), the current drug of choice for treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research